Similarly, the interaction of the high-mannose N-glycan form of CD133 with cytoplasmic DNA methyltransferase 1 (DNMT1) maintains the slow-cycling state of glioma stem cells, and favors chemotherapy resistance and tumorigenesis [158]. The gene discussed is PROM1; the disease is glioma.